The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- NTS Day 3: Railroad safety improvements driven by member reports
- NTS Day 3: America’s transit safer because of union member efforts
- TD NTS: STB chair and vice chair address officers, assure labor will have input
- TTD president: Labor needs to stick together to maintain progress
- TD National Training Seminar begins; officers train to confidently represent union members
- SMART-TD transit union conducts first Bus/Transit Day on the Hill
- Chairperson ensures that new bus members get what’s owed to them
- LACMTA reconstitutes in-agency police force to protect workers, riders
- Open enrollment for the SMART-TD VLTD and VLIFE plans begins for rail and bus members
- SMART-TD excited to welcome Coaster to its passenger rail/commuter family